MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma.
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 80 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 80 samples: 63 distinct titles, 17 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcomaNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE274640_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1147313 and SRA study SRP525883. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 80 sample titles: 63 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8453997 RD_HDR_L122R_WT_RD-93_S14
- GSM8453998 RD_HDR_L122R_WT_RD-11_S13
- GSM8453999 RD_HDR_Ctrl_RD-60_S12
- GSM8454000 RD_HDR_L122R_WT_C11r1_A03_S03
- GSM8454001 RD_HDR_L122R_WT_C11r2_A09_S09
- GSM8454002 RD_HDR_L122R_WT_C93r1_A04_S04
- GSM8454003 RD_HDR_L122R_WT_C93r2_A10_S10
- GSM8454004 RD_HDR_WT_WT_C60r1_A02_S02
- GSM8454005 RD_HDR_WT_WT_C60r2_A08_S08
- GSM8454006 RD_HDR_WT_WT_C9r1_A01_S01
- GSM8454007 RD_HDR_WT_WT_C9r2_A07_S07
- GSM8454008 RD_OE_L122R_FLAG_r1_C12_S36
- GSM8454009 RD_OE_L122R_FLAG_r2_D9_S45
- GSM8454010 RD_OE_L122R_HA_r1_C8_S32
- GSM8454011 RD_OE_L122R_HA_r2_D5_S41
- GSM8454012 RD_OE_MYOD1_FLAG_r1_C10_S34
- GSM8454013 RD_OE_MYOD1_FLAG_r2_D7_S43
- GSM8454014 RD_OE_MYOD1_HA_r1_C6_S30
- GSM8454015 RD_OE_MYOD1_HA_r2_D3_S39
- GSM8454016 RD_OE_L122R_RDL122R-1_S3
- GSM8454017 RD_OE_L122R_RDL122R-2_S8
- GSM8454018 RD_OE_MYOD1_RDMyoD1-1_S2
- GSM8454019 RD_OE_MYOD1_RDMyoD-2_S7
- GSM8454020 RD_Plain_r1_C04
- GSM8454021 RD_Plain_r2_D01
- GSM8454022 RD_Plain_r3_D10
- GSM8454023 Ruch2_OE_L122R_r1_B5_S17
- GSM8454024 Ruch2_OE_L122R_r2_B10_S22
- GSM8454025 Ruch2_OE_L122R_r3_C3_S27
- GSM8454026 Ruch2_OE_MYOD1_r1_B3_S15
- GSM8454027 Ruch2_OE_MYOD1_r2_B8_S20
- GSM8454028 Ruch2_OE_MYOD1_r3_C1_S25
- GSM8454029 Ruch2_-Dox_L122R_B4_S16
- GSM8454030 Ruch2_-Dox_L122R_B9_S21
- GSM8454031 Ruch2_-Dox_L122R_C2_S26
- GSM8454032 Ruch2_-Dox_MYOD1_B2_S14
- GSM8454033 Ruch2_-Dox_MYOD1_B7_S19
- GSM8454034 Ruch2_-Dox_MYOD1_B12_S24
- GSM8454035 Ruch2_Plain_B1_S13
- GSM8454036 Ruch2_Plain_B6_S18
+ 40 more — browse all 80 samples with per-sample file links →
- GSE312030 Combined inhibition of HRAS and MEK induces tumor regression and restores myogenic differentiation in HRAS-mutant rhabdomyosarcoma 159 samples same disease briefing · shares rhabdomyosarcoma, induces
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares rhabdomyosarcoma, induces
- GSE279337 Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma 40 samples same disease briefing · shares rhabdomyosarcoma
- GSE276201 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma 28 samples same disease briefing · shares rhabdomyosarcoma
- GSE303028 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma 104 samples same disease briefing · shares rhabdomyosarcoma
- GSE253895 PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma 58 samples same disease briefing · shares rhabdomyosarcoma
- GSE303151 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [CUT&RUN] 50 samples same disease briefing · shares rhabdomyosarcoma
- GSE268193 Gene Expression in Human Rhabdomyosarcoma 32 samples same disease briefing · shares rhabdomyosarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.